Growth Differentiation Factor 9
"Growth Differentiation Factor 9" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A bone morphogenetic protein that plays an essential role in the regulation of ovarian folliculogenesis.
Descriptor ID |
D055429
|
MeSH Number(s) |
D12.644.276.954.300.800 D12.776.467.942.300.800 D23.529.942.300.800
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Growth Differentiation Factor 9".
Below are MeSH descriptors whose meaning is more specific than "Growth Differentiation Factor 9".
This graph shows the total number of publications written about "Growth Differentiation Factor 9" by people in this website by year, and whether "Growth Differentiation Factor 9" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2014 | 1 | 0 | 1 |
2019 | 2 | 0 | 2 |
2021 | 1 | 0 | 1 |
2022 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Growth Differentiation Factor 9" by people in Profiles.
-
Riepsamen AH, Donoghoe MW, Indran IR, Hechtman L, Robertson DM, Gilchrist RB, Ledger WL, Yong EL. Serum GDF9 and BMP15 as potential markers of ovarian function in women with and without polycystic ovary syndrome. Clin Endocrinol (Oxf). 2023 04; 98(4):567-577.
-
Shamsa A, Gilchrist RB, Robertson DM, Rodgers RJ, Donoghoe MW, Ledger WL, Abbott JA, Riepsamen AH. Oocyte-Secreted Serum Biomarkers GDF9 and BMP15 in Women with Endometriosis. Reprod Sci. 2023 05; 30(5):1521-1527.
-
Riepsamen AH, Donoghoe MW, Baerwald A, Pankhurst MW, Lien S, Chong YH, Robertson DM, Ledger WL, Gilchrist RB. Exploratory analysis of serum concentrations of oocyte biomarkers growth differentiation factor 9 and bone morphogenetic protein 15 in ovulatory women across the menstrual cycle. Fertil Steril. 2021 08; 116(2):546-557.
-
Riepsamen AH, Chan K, Lien S, Sweeten P, Donoghoe MW, Walker G, Fraison EHJ, Stocker WA, Walton KL, Harrison CA, Ledger WL, Robertson DM, Gilchrist RB. Serum Concentrations of Oocyte-Secreted Factors BMP15 and GDF9 During IVF and in Women With Reproductive Pathologies. Endocrinology. 2019 10 01; 160(10):2298-2313.
-
Richani D, Constance K, Lien S, Agapiou D, Stocker WA, Hedger MP, Ledger WL, Thompson JG, Robertson DM, Mottershead DG, Walton KL, Harrison CA, Gilchrist RB. Cumulin and FSH Cooperate to Regulate Inhibin B and Activin B Production by Human Granulosa-Lutein Cells In Vitro. Endocrinology. 2019 04 01; 160(4):853-862.
-
Simpson CM, Robertson DM, Al-Musawi SL, Heath DA, McNatty KP, Ritter LJ, Mottershead DG, Gilchrist RB, Harrison CA, Stanton PG. Aberrant GDF9 expression and activation are associated with common human ovarian disorders. J Clin Endocrinol Metab. 2014 Apr; 99(4):E615-24.
-
Griffith GJ, Trask MC, Hiller J, Walentuk M, Pawlak JB, Tremblay KD, Mager J. Yin-yang1 is required in the mammalian oocyte for follicle expansion. Biol Reprod. 2011 Apr; 84(4):654-63.
-
Racki WJ, Richter JD. CPEB controls oocyte growth and follicle development in the mouse. Development. 2006 Nov; 133(22):4527-37.